![Aram Andrew Mangasarian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aram Andrew Mangasarian
Amministratore Delegato presso TME PHARMA N.V.
Profilo
Aram Andrew Mangasarian is currently the Chief Executive Officer & Non-Executive Director at NOXXON Pharma AG since 2015.
He is also the Chief Executive Officer at TME Pharma NV since 2015.
Additionally, he holds the position of Director at NOXXON Pharma NV Niederlassung Deutschland.
Previously, he worked as a Director at Caerus Consulting AS.
From 2020 to 2023, he served as an Independent Director at Isofol Medical AB.
He was the Vice President-Development Affairs at Novexel SA from 2005 to 2012.
He also worked as a Manager at Exonhit from 2000 to 2012 and as the Vice President-Business Development at Eurobio-Scientific SA. Dr. Mangasarian completed his undergraduate degree at the University of Wisconsin.
He holds an MBA from INSEAD and a doctorate from the University of California San Diego.
Posizioni attive di Aram Andrew Mangasarian
Società | Posizione | Inizio |
---|---|---|
TME PHARMA N.V. | Amministratore Delegato | 01/05/2010 |
NOXXON Pharma AG
![]() NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Amministratore Delegato | 01/05/2010 |
NOXXON Pharma NV Niederlassung Deutschland
![]() NOXXON Pharma NV Niederlassung Deutschland BiotechnologyHealth Technology NOXXON Pharma NV Niederlassung Deutschland operates as a German biotechnology company. The private company is based in Berlin, Germany. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Aram Andrew Mangasarian
Società | Posizione | Fine |
---|---|---|
ISOFOL MEDICAL AB | Direttore/Membro del Consiglio | 01/02/2023 |
EUROBIO SCIENTIFIC | Corporate Officer/Principal | - |
Exonhit
![]() Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Caerus Consulting AS
![]() Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Direttore/Membro del Consiglio | - |
Novexel SA
![]() Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Corporate Officer/Principal | - |
Formazione di Aram Andrew Mangasarian
INSEAD | Masters Business Admin |
University of California San Diego | Doctorate Degree |
University of Wisconsin | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
TME PHARMA N.V. | Health Technology |
EUROBIO SCIENTIFIC | Health Technology |
ISOFOL MEDICAL AB | Health Technology |
Aziende private | 5 |
---|---|
Novexel SA
![]() Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Health Technology |
Exonhit
![]() Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
NOXXON Pharma AG
![]() NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Health Technology |
Caerus Consulting AS
![]() Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Health Technology |
NOXXON Pharma NV Niederlassung Deutschland
![]() NOXXON Pharma NV Niederlassung Deutschland BiotechnologyHealth Technology NOXXON Pharma NV Niederlassung Deutschland operates as a German biotechnology company. The private company is based in Berlin, Germany. | Health Technology |
- Borsa valori
- Insiders
- Aram Andrew Mangasarian